Literature DB >> 22192887

A framework for the evaluation of new interventional procedures.

Tania Lourenco1, Adrian M Grant, Jennifer M Burr, Luke Vale.   

Abstract

OBJECTIVES: The introduction of new interventional procedures is less regulated than for other health technologies such as pharmaceuticals. Decisions are often taken on evidence of efficacy and short-term safety from small-scale usually observational studies. This reflects the particular challenges of evaluating interventional procedures - the extra facets of skill and training and the difficulty defining a 'new' technology. Currently, there is no framework to evaluate new interventional procedures before they become available in clinical practice as opposed to new pharmaceuticals. This paper proposes a framework to guide the evaluation of a new interventional procedure. PROPOSED FRAMEWORK: A framework was developed consisting of a four-stage progressive evaluation for a new interventional procedure: Stage 1: Development; Stage 2: Efficacy and short-term safety; Stage 3: Effectiveness and cost-effectiveness; and Stage 4: Implementation. The framework also suggests the types of studies or data collection methods that can be used to satisfy each stage.
CONCLUSIONS: This paper makes a first step on a framework for generating evidence on new interventional procedures. The difficulties and limitations of applying such a framework are discussed.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2011        PMID: 22192887     DOI: 10.1016/j.healthpol.2011.11.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  1 in total

1.  Suggestions for health information technology trials for respiratory disorders in low- and middle-income country settings: what can we learn from trials in high-income country settings?

Authors:  Niels H Chavannes; Robert S Du Puy; Chunxue Bai
Journal:  NPJ Prim Care Respir Med       Date:  2015-07-09       Impact factor: 2.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.